Sir Andrew Witty is the CEO of GlaxoSmithKline, a British pharmaceutical company that counts itself as one of the fifth or sixth largest in the industry. Marketplace host, Kai Ryssdal talked to him about the cost of pharmaceuticals, R&D and preparing for epidemics.
Click the audio player above or subscribe to the Corner Office podcast to listen to the full interview.
Thanks to our
Your support keeps us going strong, even through